LitCovid-sentences  

PMC:7102560 / 374-1916 JSONTXT 11 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T7 0-7 Sentence denotes Summary
T8 9-19 Sentence denotes Objectives
T9 20-173 Sentence denotes Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population.
T10 174-288 Sentence denotes However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation.
T11 289-378 Sentence denotes This study aimed to evaluate the clinical characteristics of the SARS-CoV-2 reactivation.
T12 380-387 Sentence denotes Methods
T13 388-686 Sentence denotes Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for 55 patients with laboratory-confirmed COVID-19 pneumonia (i.e., with throat swab samples that were positive for SARS-CoV-2) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan.
T14 687-696 Sentence denotes 8 to Feb.
T15 697-706 Sentence denotes 10, 2020.
T16 708-715 Sentence denotes Results
T17 716-875 Sentence denotes All 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation.
T18 876-994 Sentence denotes Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue.
T19 995-1149 Sentence denotes One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L).
T20 1150-1218 Sentence denotes All 5 reactivated patients presented normal aminotransferase levels.
T21 1219-1337 Sentence denotes Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus.
T22 1339-1350 Sentence denotes Conclusions
T23 1351-1542 Sentence denotes Findings from this small group of cases suggested that there was currently evidence for reactivation of SARS-CoV-2 and there might be no specific clinical characteristics to distinguish them.